Tier 3 — preclinical

The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus

Kawai N, Sakai N, Okuro M, Karakawa S, Tsuneyoshi Y, Kawasaki N, Takeda T, Bannai M, Nishino S
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2015 40(6):1405-1416

Bibliography

PubMed
PMID 25533534
PubMed Central
PMC4397399
Funding
Ajinomoto funded the work of N. Sakai, M. Okuro and S. Nishino, according to the funding and disclosure statement.
Competing interests
The disclosure identifies four authors as Ajinomoto employees and three authors as recipients of Ajinomoto funding.

Study snapshot

DesignControlled animal intervention with mechanistic experiments
ModelRats; oral and intracranial interventions
SampleMultiple rat experiments; group sizes vary by experiment
InterventionOral glycine and targeted brain injections, with receptor antagonists and SCN ablation
DurationAcute experiments
EndpointsNREM sleep latency; Core temperature; Cutaneous blood flow; NMDA signaling

What the study showed, in plain terms

Rat experiments link glycine-induced sleep and cooling to NMDA signaling in the suprachiasmatic nucleus. The work provides a plausible mechanism for studying bedtime glycine in humans.

Key findings

  • Glycine promoted heat loss and shortened NREM sleep latency in the tested model.
  • Blocking NMDA signaling or ablating the SCN prevented key effects.

What this study can and cannot tell us

Brain injections and experimentally disrupted sleep do not reproduce ordinary oral supplementation in humans.

The experiments do not establish an optimal human dose or chronic sleep benefit.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified